This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (55)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Surgical Oncology  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Alert me on articles by topic

Karen T. Pitman, MD; Jonas T. Johnson, MD; Howard Edington, MD; E. Leon Barnes, MD; Roger Day, ScD; Robin L. Wagner; Eugene N. Myers, MD

Arch Otolaryngol Head Neck Surg. 1998;124:790-793.

Objective  To determine whether intraoperative lymphatic mapping with isosulfan blue dye and sentinel lymph node biopsy accurately demonstrates the pathway of regional metastases from mucosal sites in squamous cell carcinoma of the head and neck.

Design  A prospective clinical study of intraoperative lymphatic mapping.

Setting  An academic tertiary referral center.

Patients  Patients with previously untreated squamous cell carcinoma of the head and neck whose surgical treatment included neck dissection.

Intervention  Injection of isosulfan blue dye into the mucosa surrounding squamous cell carcinomas of the upper aerodigestive tract during cervical lymphadenectomy.

Outcome Measures  Correlation of the pathologic findings in the blue sentinel lymph node with those in the remaining cervical lymphatics.

Results  No blue-stained cervical lymphatics were identified after injection of the mucosa surrounding the primary squamous cell carcinoma with isosulfan dye.

Conclusion  The technique of intraoperative lymphatic mapping with isosulfan blue dye requires further study before it can be used for the detection of occult cervical metastases in squamous cell carcinoma of the head and neck.

From the Departments of Otolaryngology (Drs Pitman, Johnson, and Myers and Ms Wagner), Plastic Surgery (Dr Edington), and Pathology (Dr Barnes), University of Pittsburgh School of Medicine, and the Department of Biostatistics, University of Pittsburgh Cancer Institute (Dr Day), Pittsburgh, Pa. Dr Pitman is now with the Department of Otolaryngology, Naval Medical Center, Portsmouth, Va.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinel Node Biopsy in N0 Squamous Cell Carcinoma of the Oral Cavity and Oropharynx in Patients Previously Treated With Surgery or Radiation Therapy: A Pilot Study
Hart et al.
Arch Otolaryngol Head Neck Surg 2007;133:806-809.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy in N0 Squamous Cell Carcinoma of the Oral Cavity and Oropharynx
Hart et al.
Arch Otolaryngol Head Neck Surg 2005;131:34-38.
ABSTRACT | FULL TEXT  

Editorial: Sentinel Lymph Node Biopsy For Early Stage Clinical N0 Squamous Cell Carcinoma of the Oral Cavity
Loree
Ann. Surg. Oncol. 2004;11:725-726.
FULL TEXT  

Sentinel Node Biopsy in Head and Neck Cancer: Preliminary Results of a Multicenter Trial
Ross et al.
Ann. Surg. Oncol. 2004;11:690-696.
ABSTRACT | FULL TEXT  

Value of Sentinel Lymphadenectomy in Head and Neck Cancer
Werner et al.
Ann. Surg. Oncol. 2004;11:267S-270S.
ABSTRACT | FULL TEXT  

Neck Dissection: An Operation in Evolution: Hayes Martin Lecture
Myers and Gastman
Arch Otolaryngol Head Neck Surg 2003;129:14-25.
FULL TEXT  

Fine-Needle Aspiration Cytology of the Sentinel Lymph Node in Head and Neck Cancer
Hoft et al.
JNM 2002;43:1585-1590.
ABSTRACT | FULL TEXT  

Sentinel Node Localization in Oral Cavity and Oropharynx Squamous Cell Cancer
Taylor et al.
Arch Otolaryngol Head Neck Surg 2001;127:970-974.
ABSTRACT | FULL TEXT